Tour de Cure is a non-profit organisation that organises tours and events across Australia to fund pioneering Australian cancer projects.  The Insurance Advisernet Foundation (IA) is pleased to support Tour de Cure by making a $25,000 donation to help fund the work of Australian scientists who have dedicated their lives to uncovering a cure for cancer. 

This donation was facilitated by Gareth Jones, Principal of Partenaire Solutions, and an Authorised Representative of IA. 

Like most Australians, Gareth has been personally affected by cancer so he’s passionate about supporting Tour de Cure. He’s participated in numerous riding tours and has personally fundraised a significant amount of money for cancer research, support and prevention projects. 

IA Managing Director, Shaun Standfield and General Manager for NSW/ACT, Simon Elliot, were on hand in Cairns to present the $25,000 IA donation cheque to Mark Beretta live on Channel 7's Sunrise.

Tour de Cure – Riding to Cure Cancer

Since 2007, Tour de Cure has raised $35 million, funded 306 world-class cancer projects and achieved 22 significant cancer breakthroughs. The organisation has also helped to educate more than 90,000 Australian primary school children about cancer awareness and prevention through its Be Fit, Be Healthy, Be Happy program.

The Tour de Cure Signature Tour is its flagship event, but there are a variety of shorter tours and events in different locations across Australia each year. There are numerous ways to get involved with Tour de Cure, including riding, volunteering, fundraising or simply by making a personal or company donation. 

IA fully supports and encourages the efforts of staff members like Gareth Jones, who selflessly give of their own free time to support organisations like Tour de Cure. In honour of Tour de Cure’s mission to find a cure for cancer, IA are very proud to make their $25,000 donation to this inspiring and well-deserving charity.

Visit the Tour de Cure Website for more information:


Insurance Advisernet , May 03 2018

Back to news